▁This 10.375
▁type 10.265625
▁of 0.666015625
▁study 6.37109375
▁is 1.8271484375
▁the 3.640625
▁most 3.05078125
▁reve 8.34375
aling 0.040008544921875
▁and 2.220703125
▁inclus 8.46875
ive 0.01546478271484375
, 3.623046875
▁as 2.958984375
▁it 1.4765625
▁contains 4.80078125
▁direct 8.2890625
▁responses 5.62109375
▁from 1.2138671875
▁a 3.5625
▁large 2.689453125
▁number 2.0390625
▁of 0.058502197265625
▁participants 2.400390625
. 1.0458984375
▁All 4.546875
▁tools 9.03125
▁in 4.08203125
▁the 0.89208984375
▁form 5.73046875
▁of 0.626953125
▁question 2.927734375
na 0.085205078125
ires 0.0002422332763671875
▁and 2.119140625
▁scales 3.572265625
▁have 2.50390625
▁already 4.1328125
▁been 0.138671875
▁used 2.447265625
▁and 2.44140625
▁proved 5.6171875
▁their 2.67578125
▁effic 3.79296875
acy 0.0032138824462890625
▁for 3.501953125
▁collect 6.7734375
ing 0.11761474609375
▁analyt 9.359375
ical 0.431640625
▁data 0.73974609375
. 1.1015625
▁It 4.23828125
▁helps 6.203125
▁to 0.97509765625
▁system 6.8203125
at 1.041015625
ize 0.07159423828125
▁and 1.5712890625
▁class 3.763671875
ify 0.010101318359375
▁distinct 9.5859375
▁kinds 6.01953125
▁of 0.04705810546875
▁information 2.83984375
▁for 3.63671875
▁subsequent 4.58203125
▁un 7.8125
comp 6.53515625
licated 0.154296875
▁services 10.6484375
. 0.87451171875
▁Thus 5.19921875
, 0.1571044921875
▁research 5.7578125
ers 1.1748046875
▁can 1.748046875
▁compare 5.24609375
▁the 1.3359375
▁effects 4.578125
▁of 0.2349853515625
▁medic 5.76953125
ations 1.1796875
▁on 1.607421875
▁patients 2.921875
▁of 3.5625
▁diverse 4.5703125
▁age 2.705078125
▁groups 0.51513671875
, 1.0810546875
▁background 5.29296875
s 0.2445068359375
, 0.1739501953125
▁physical 5.14453125
▁conditions 1.8642578125
, 0.1861572265625
▁emot 5.9296875
ional 0.06329345703125
▁states 1.2158203125
, 0.171875
▁and 0.8525390625
▁so 2.62890625
▁on 0.83984375
. 0.2352294921875
<0x0A> 0.85009765625
The 1.4755859375
▁study 2.87109375
▁was 2.375
▁conducted 1.06640625
▁in 1.36328125
▁the 1.681640625
▁form 1.2216796875
▁of 0.005847930908203125
▁collection 9.2890625
▁and 1.6162109375
▁analysis 0.96630859375
▁of 0.041900634765625
▁statistical 3.947265625
▁data 0.136474609375
. 1.09765625
▁Part 5.65625
icip 0.0546875
ants 0.05072021484375
▁were 0.814453125
▁rec 3.548828125
ru 0.0008211135864257812
ited 0.00016176700592041016
▁for 3.6328125
▁six 8.15625
▁months 0.6015625
▁at 4.08984375
▁two 2.830078125
▁major 4.84375
▁pain 10.0234375
▁relief 4.72265625
▁cent 1.5126953125
ers 0.10968017578125
▁in 0.74072265625
▁Israel 4.30078125
. 0.70361328125
▁The 1.3173828125
▁research 3.169921875
ers 0.85009765625
▁used 2.63671875
▁The 8.8359375
▁De 6.40625
pression 0.1630859375
▁Module 8.171875
▁of 1.134765625
▁the 0.28076171875
▁Pat 2.77734375
ient 0.009735107421875
▁Health 0.286376953125
▁Question 0.0162811279296875
naire 0.0152130126953125
▁and 3.697265625
▁the 0.7578125
▁General 3.130859375
ized 1.111328125
▁An 0.0174713134765625
x 0.00021767616271972656
iety 0.0009660720825195312
▁Dis 0.51513671875
order 0.034637451171875
▁Sc 1.5908203125
ale 0.019866943359375
▁to 2.0546875
▁interview 7.1796875
▁participants 1.8955078125
, 2.8671875
▁evaluate 5.74609375
▁their 0.67138671875
▁answers 5.5234375
, 0.541015625
▁and 0.1234130859375
▁conduct 4.48046875
▁the 2.134765625
▁study 1.9287109375
. 0.2548828125
▁To 5.27734375
▁specifically 9.828125
▁evaluate 2.41796875
▁and 3.6484375
▁compare 1.5771484375
▁the 0.409423828125
▁prob 11.1953125
abilities 0.21630859375
▁of 0.198974609375
▁de 3.525390625
pression 0.0819091796875
▁or 4.01953125
▁anx 0.10357666015625
iety 0.00031566619873046875
▁among 2.64453125
▁the 1.7705078125
▁diverse 6.89453125
▁groups 1.5615234375
, 1.396484375
▁the 1.126953125
▁study 2.859375
▁used 1.5849609375
▁multiple 4.97265625
▁log 2.84765625
istic 0.028778076171875
▁regression 0.0869140625
▁analysis 0.6083984375
▁and 2.61328125
▁chose 8.96875
▁medical 8.1328125
▁mar 9.234375
iju 0.0057220458984375
ana 4.0650367736816406e-05
▁as 0.91064453125
▁the 0.7158203125
▁control 3.08984375
▁group 0.56591796875
. 0.3330078125
<0x0A> 0.908203125
Chr 9.171875
onic 0.1517333984375
▁pain 0.460693359375
▁is 0.896484375
▁still 6.2734375
▁considered 2.34375
▁to 2.0
▁be 0.0206756591796875
▁an 2.3515625
▁extreme 5.8828125
▁issue 4.52734375
▁among 3.5078125
▁at 9.4609375
▁least 0.347900390625
▁ 0.61669921875
8 2.533203125
% 3.8046875
▁of 0.04754638671875
▁the 0.379638671875
▁residents 7.6875
▁of 0.46533203125
▁progress 12.578125
ive 0.3583984375
▁countries 1.068359375
. 0.88818359375
▁The 2.04296875
▁introduction 6.6484375
▁of 0.08203125
▁the 2.671875
▁study 3.10546875
▁describes 8.96875
▁the 0.78515625
▁apparent 8.421875
▁link 4.96484375
▁between 0.1727294921875
▁pain 3.224609375
▁and 0.449951171875
▁dem 9.265625
oral 3.0390625
ization 0.1331787109375
. 1.3251953125
▁Chron 4.2578125
ic 0.0038051605224609375
▁pain 0.11041259765625
▁is 1.2431640625
▁always 5.83984375
▁accompanied 0.953125
▁by 0.048370361328125
▁negative 4.0703125
▁emot 1.0703125
ional 1.3486328125
▁experiences 4.27734375
▁and 1.921875
▁blocks 9.8046875
▁a 3.75390625
▁person 0.7001953125
’ 26.609375
s 0.67236328125
▁ability 1.2744140625
▁to 0.016845703125
▁receive 6.3125
▁joy 4.31640625
▁and 1.236328125
▁satisfaction 3.0078125
▁from 1.1064453125
▁life 0.986328125
. 0.267578125
▁The 1.87109375
▁research 3.27734375
▁investig 5.60546875
ates 0.74658203125
▁the 0.467041015625
▁development 7.06640625
▁of 0.189453125
▁de 1.6171875
pression 0.1243896484375
▁and 0.7021484375
▁anx 0.2078857421875
iety 0.0019397735595703125
▁among 1.486328125
▁patients 1.138671875
▁receiving 4.859375
▁ph 5.58984375
arma 0.64111328125
ce 0.002208709716796875
ut 9.822845458984375e-05
ical 0.0035648345947265625
▁op 5.12890625
io 0.2646484375
ids 0.4345703125
▁and 1.5966796875
▁medical 1.3076171875
▁mar 0.1815185546875
iju 0.004276275634765625
ana 0.00033164024353027344
▁( 4.74609375
MM 2.529296875
) 2.197265625
▁as 1.5517578125
▁severe 11.0234375
▁pain 1.0185546875
kill 1.9658203125
ers 0.0002665519714355469
. 0.353515625
▁It 2.67578125
▁comp 3.953125
ares 0.034698486328125
▁the 0.46044921875
▁effic 4.49609375
acy 0.000957489013671875
▁of 0.2393798828125
▁pres 5.9140625
cri 1.3642578125
ptions 0.74609375
▁and 1.92578125
▁exam 5.0234375
ines 0.00847625732421875
▁the 0.423095703125
▁possibility 3.3828125
▁of 0.102783203125
▁post 6.55078125
- 0.81640625
tre 1.6630859375
at 0.0007791519165039062
ment 0.0028285980224609375
▁de 2.041015625
pression 0.04486083984375
. 2.369140625
<0x0A> 0.7431640625
There 4.62109375
▁is 0.9248046875
▁currently 4.4765625
▁a 1.3154296875
▁severe 5.078125
▁lack 2.51953125
▁of 0.0179901123046875
▁information 2.416015625
▁about 1.3935546875
▁the 0.4814453125
▁effects 2.681640625
▁of 0.078125
▁op 2.306640625
i 4.0234375
ates 0.07080078125
. 4.265625
▁They 4.8515625
▁manage 8.3359375
▁pain 3.115234375
▁successfully 5.65625
, 0.97509765625
▁but 0.301513671875
▁the 2.46875
▁past 9.4296875
▁few 2.896484375
▁dec 0.73388671875
ades 7.128715515136719e-05
▁indicated 9.265625
▁the 1.908203125
▁growing 4.3359375
▁concern 3.76953125
▁regarding 2.671875
▁op 3.888671875
iate 0.80615234375
▁ab 1.7890625
use 0.00928497314453125
▁in 3.4765625
▁forms 10.0
▁of 0.2998046875
▁over 2.955078125
d 0.323974609375
ose 0.31591796875
▁and 0.65673828125
▁add 0.99755859375
iction 0.0262451171875
. 0.19189453125
▁A 4.234375
▁more 5.4375
▁manage 8.9296875
able 0.0010633468627929688
▁and 1.9326171875
▁sa 2.5625
fer 6.389617919921875e-05
▁alternative 1.5087890625
▁might 6.7421875
▁be 0.277587890625
▁medical 2.52734375
▁mar 0.095458984375
iju 0.0029773712158203125
ana 0.0004105567932128906
. 1.2431640625
▁However 3.759765625
, 0.0023822784423828125
▁the 1.572265625
▁legal 4.75390625
▁status 1.220703125
▁and 2.833984375
▁novel 8.9375
ty 0.459716796875
▁of 0.1859130859375
▁this 1.71484375
▁drug 2.501953125
▁do 4.8046875
▁not 0.07330322265625
▁allow 0.8427734375
▁finding 8.21875
▁a 2.486328125
▁large 4.1796875
▁number 1.12109375
▁of 0.0029697418212890625
▁studies 1.5283203125
▁on 1.5361328125
▁its 0.78076171875
▁effect 2.103515625
iveness 0.11383056640625
. 0.8505859375
▁Specifically 8.3359375
, 0.12841796875
▁it 2.853515625
▁concerns 5.2890625
▁the 0.73388671875
▁emot 7.359375
ional 0.0189056396484375
▁condition 4.4453125
▁of 0.305908203125
▁patients 0.55615234375
▁experien 6.421875
cing 3.5881996154785156e-05
▁chron 1.296875
ic 0.0010900497436523438
▁pain 0.10491943359375
. 0.66650390625
▁This 3.439453125
▁research 3.474609375
▁paper 6.7109375
▁a 2.7265625
ims 0.0007872581481933594
▁to 0.09161376953125
▁analyze 3.251953125
▁levels 10.1171875
▁of 0.03985595703125
▁de 0.428955078125
pression 0.022735595703125
▁and 0.17724609375
▁anx 0.029266357421875
iety 0.0008230209350585938
▁among 0.76953125
▁people 3.625
▁receiving 1.259765625
▁ther 7.984375
apy 0.311279296875
▁by 4.8125
▁comparing 7.15625
▁the 0.85009765625
▁effects 1.880859375
▁of 0.03265380859375
▁ph 2.158203125
arma 0.033599853515625
ce 0.001270294189453125
ut 4.410743713378906e-05
ical 0.0037288665771484375
▁op 0.50244140625
io 0.1634521484375
ids 0.06719970703125
▁and 0.3173828125
▁MM 0.92236328125
. 1.0673828125
<0x0A> 0.63232421875
The 1.150390625
▁analysis 4.93359375
▁of 0.79443359375
▁any 8.2265625
▁human 5.6875
▁reaction 5.14453125
▁has 4.92578125
▁a 1.9033203125
▁high 4.78515625
▁potential 3.029296875
▁of 1.5859375
▁subject 6.15625
iveness 3.900390625
▁and 1.4248046875
▁bias 2.25390625
, 2.1484375
▁especially 2.310546875
▁regarding 4.1484375
▁people 4.62109375
▁in 3.71875
▁severe 3.89453125
▁pain 0.410400390625
▁and 2.66015625
▁un 5.40625
stable 1.9140625
▁emot 0.806640625
ional 0.198974609375
▁condition 2.861328125
. 0.0714111328125
▁Perhaps 8.4765625
▁some 5.21484375
▁patients 2.177734375
▁tend 5.765625
▁to 0.0198211669921875
▁ex 2.826171875
agger 0.0030994415283203125
ate 0.005786895751953125
▁their 0.79052734375
▁de 4.484375
press 1.7685546875
ive 0.299560546875
▁state 3.099609375
▁or 2.09375
▁vice 7.13671875
▁vers 0.0207366943359375
a 8.666515350341797e-05
, 1.0341796875
▁de 7.21484375
- 5.11328125
emph 1.220703125
as 0.005046844482421875
ize 0.12109375
▁serious 6.80859375
▁difficulties 6.36328125
. 0.919921875
▁Because 6.16796875
▁the 2.373046875
▁survey 6.96484375
▁responses 7.65234375
▁were 1.48046875
▁thoroughly 8.046875
▁anonymous 5.27734375
, 0.463134765625
▁the 1.2998046875
▁research 1.41796875
ers 0.7509765625
▁were 1.560546875
▁unable 2.302734375
▁to 0.00307464599609375
▁carefully 8.5390625
▁analyze 1.486328125
▁each 3.86328125
▁patient 2.005859375
’ 26.796875
s 0.01727294921875
▁reaction 3.7734375
▁and 2.484375
▁compare 3.1640625
▁it 1.02734375
▁to 1.0361328125
▁the 0.837890625
▁actual 5.11328125
▁states 7.50390625
▁of 0.53759765625
▁condition 7.359375
. 0.410400390625
▁More 6.7109375
▁accurate 3.9453125
▁answers 4.82421875
▁could 2.458984375
▁be 0.9619140625
▁obtained 1.029296875
▁by 1.318359375
▁professional 7.32421875
▁psych 2.197265625
olog 0.34814453125
ists 0.001461029052734375
▁via 8.171875
▁personal 4.29296875
▁communication 4.76171875
▁and 1.8251953125
▁behavior 7.00390625
al 0.340087890625
▁analysis 2.125
. 0.2479248046875
▁However 2.8828125
, 0.002288818359375
▁this 2.16796875
▁method 3.6796875
▁of 2.16015625
▁research 2.09765625
▁is 1.0185546875
▁way 7.98046875
▁more 1.8857421875
▁resource 5.67578125
- 0.43896484375
int 0.57275390625
ensive 0.00923919677734375
▁and 0.72021484375
▁energy 8.65625
- 0.11444091796875
consum 0.318359375
ing 0.0020313262939453125
. 0.68115234375
<0x0A> 0.666015625
Part 5.30859375
icip 0.1766357421875
ants 0.1258544921875
▁were 1.0283203125
▁rec 1.3388671875
ru 0.0015010833740234375
ited 3.921985626220703e-05
▁for 1.0224609375
▁six 0.86083984375
▁months 0.01522064208984375
▁at 0.33251953125
▁two 0.0687255859375
▁major 0.185302734375
▁pain 0.0181427001953125
▁relief 0.00803375244140625
▁cent 0.01297760009765625
ers 0.003383636474609375
▁in 0.040557861328125
▁Israel 0.022369384765625
. 0.1522216796875
▁All 3.87109375
▁patients 1.4306640625
▁experienced 5.73046875
▁chron 1.4140625
ic 0.0008416175842285156
▁pain 0.11444091796875
▁for 2.787109375
▁at 0.67431640625
▁least 0.0009202957153320312
▁ 1.50390625
3 1.3515625
▁months 0.259521484375
. 0.89599609375
▁The 1.2734375
▁study 1.9560546875
▁included 2.517578125
▁ 1.087890625
8 2.900390625
9 2.833984375
0 3.974609375
▁participants 1.498046875
, 1.322265625
▁of 1.9609375
▁which 0.400390625
▁ 0.154541015625
4 1.533203125
7 2.515625
4 2.8046875
▁( 2.373046875
5 0.0906982421875
9 11.28125
%) 0.9794921875
▁were 0.53759765625
▁treated 4.51953125
▁sole 6.7421875
ly 0.00010156631469726562
▁with 0.460693359375
▁op 0.76513671875
io 0.37939453125
ids 0.2032470703125
, 1.2060546875
▁ 0.62890625
3 1.033203125
2 1.974609375
9 2.56640625
▁( 0.046173095703125
4 1.1357421875
1 1.189453125
%) 0.1361083984375
▁were 1.3583984375
▁treated 0.5380859375
▁with 0.197265625
▁MM 0.2919921875
, 0.223876953125
▁and 0.1505126953125
▁ 0.162353515625
7 3.24609375
7 2.419921875
▁( 0.170654296875
8 3.837890625
. 1.3076171875
6 3.052734375
%) 0.05633544921875
▁acquired 9.9296875
▁both 1.0029296875
▁( 6.83203125
Fe 10.2109375
ing 2.56640625
old 0.020355224609375
▁et 1.583984375
▁al 0.021453857421875
., 0.27587890625
▁ 0.01041412353515625
2 0.239013671875
0 0.0009679794311523438
1 0.397216796875
7 2.0703125
). 0.1326904296875
▁The 1.2958984375
▁remaining 6.94140625
▁ten 7.89453125
▁participants 1.373046875
▁who 5.73046875
▁did 1.4638671875
▁not 0.0079803466796875
▁receive 1.7392578125
▁ph 2.986328125
arma 0.05352783203125
ce 0.0015306472778320312
ut 1.4543533325195312e-05
ical 0.0035400390625
▁op 0.9365234375
io 0.0677490234375
ids 0.03192138671875
▁and 1.8564453125
▁medical 2.70703125
▁mar 0.034149169921875
iju 0.0038356781005859375
ana 0.00011467933654785156
▁were 1.2333984375
▁with 6.4453125
dra 0.11395263671875
wn 0.00012171268463134766
▁from 0.238525390625
▁the 0.09521484375
▁analysis 4.66015625
▁in 4.78515625
▁the 1.2646484375
▁research 4.4375
. 0.69287109375
▁Therefore 4.921875
, 0.00921630859375
▁it 3.951171875
▁is 0.85009765625
▁not 2.806640625
▁possible 0.6455078125
▁to 0.0206146240234375
▁compreh 6.6328125
ens 0.048492431640625
ively 0.0091094970703125
▁compare 1.6357421875
▁patients 4.57421875
▁taking 4.48828125
▁medic 4.0703125
ations 0.393310546875
▁with 0.97509765625
▁those 1.2060546875
▁who 1.2080078125
▁do 2.3359375
▁not 0.01322174072265625
. 0.82861328125
<0x0A> 0.646484375
The 1.0146484375
▁question 4.47265625
na 1.0751953125
ires 0.0001304149627685547
▁used 2.05078125
▁different 9.296875
▁variable 9.6640625
▁measures 4.15625
▁to 1.4853515625
▁collect 1.7900390625
▁information 2.01171875
. 1.734375
▁For 3.333984375
▁example 0.75927734375
, 0.01169586181640625
▁it 4.80859375
▁included 3.169921875
▁compreh 8.609375
ensive 0.0247955322265625
▁so 6.390625
cio 0.0289459228515625
- 0.323974609375
dem 0.088623046875
ographic 0.046722412109375
▁data 1.115234375
: 4.93359375
▁gender 1.6044921875
, 0.122314453125
▁age 0.2099609375
, 0.1553955078125
▁country 3.9296875
, 1.4111328125
▁type 4.46875
▁of 0.05487060546875
▁residence 3.548828125
▁( 2.693359375
urban 1.9111328125
/ 2.841796875
r 0.05389404296875
ural 0.0005888938903808594
), 0.253662109375
▁years 6.05859375
▁of 0.1851806640625
▁education 0.80322265625
, 0.1339111328125
▁and 1.8369140625
▁employ 3.78515625
ment 0.00384521484375
▁status 0.40234375
. 0.1846923828125
▁Pat 3.560546875
ients 0.08843994140625
▁were 1.08203125
▁also 0.83056640625
▁asked 0.51611328125
▁about 1.126953125
▁their 0.61962890625
▁medical 2.5234375
▁history 0.4599609375
▁over 8.7421875
▁the 0.1572265625
▁years 3.84765625
▁and 1.7646484375
▁the 2.037109375
▁current 3.248046875
▁presence 5.81640625
▁of 0.06109619140625
▁any 2.533203125
▁severe 4.45703125
▁dise 1.6552734375
ases 0.000102996826171875
▁such 4.0546875
▁as 0.00402069091796875
▁heart 2.505859375
▁failure 2.17578125
, 0.1546630859375
▁di 1.859375
ab 0.0016241073608398438
etes 0.004650115966796875
, 0.12017822265625
▁ar 3.826171875
th 0.0831298828125
rit 0.0278778076171875
is 0.01332855224609375
, 0.0379638671875
▁and 1.7021484375
▁so 0.80859375
▁on 0.029266357421875
. 0.055450439453125
▁The 1.8232421875
▁third 7.05078125
▁measure 3.875
▁of 2.19921875
▁the 1.0595703125
▁question 1.6025390625
naire 0.1875
▁was 0.953125
▁indicated 9.625
▁by 0.71875
▁information 6.68359375
▁on 1.6181640625
▁any 4.90625
▁twelve 13.296875
- 1.2236328125
month 0.53955078125
▁and 5.5859375
▁lifetime 3.50390625
▁drug 4.828125
▁and 3.2890625
▁alco 0.07110595703125
hol 9.322166442871094e-05
▁consumption 2.390625
. 0.517578125
▁In 3.529296875
▁addition 0.783203125
, 0.12493896484375
▁the 1.3388671875
▁record 8.1328125
▁included 1.7255859375
▁a 2.556640625
▁pain 6.52734375
▁measurement 4.18359375
▁scale 1.0458984375
▁from 3.48828125
▁ 0.55517578125
0 0.471923828125
▁to 0.441162109375
▁ 0.00664520263671875
1 0.0941162109375
0 0.06512451171875
▁to 4.65625
▁evaluate 1.53515625
▁dis 5.72265625
com 0.152587890625
fort 0.0009250640869140625
▁feelings 7.23828125
▁during 3.287109375
▁the 0.806640625
▁last 1.6943359375
▁month 1.578125
. 0.311279296875
<0x0A> 1.2421875
The 0.92236328125
▁study 2.2421875
▁conducted 4.71875
▁a 2.203125
▁correlation 6.09375
▁type 7.71484375
▁of 0.2135009765625
▁research 2.2265625
▁with 2.806640625
▁variable 8.5078125
▁measures 2.08984375
. 1.5283203125
▁It 2.818359375
▁evaluated 4.015625
▁the 0.62451171875
▁inter 6.1328125
dep 3.595703125
end 0.0008006095886230469
ence 0.01526641845703125
▁of 0.5703125
▁various 3.560546875
▁factors 1.6435546875
▁that 3.021484375
▁affected 3.830078125
▁the 0.66552734375
▁physical 6.9296875
▁and 0.9140625
▁emot 0.69091796875
ional 0.0005526542663574219
▁condition 1.13671875
▁of 0.11578369140625
▁patients 0.50732421875
▁experien 5.05078125
cing 3.921985626220703e-05
▁chron 0.401611328125
ic 0.0004534721374511719
▁pain 0.02685546875
. 0.1976318359375
▁For 2.638671875
▁example 0.398681640625
, 0.0076141357421875
▁the 1.1884765625
▁survey 4.90234375
▁showed 3.607421875
▁that 0.48974609375
▁the 1.703125
▁ratio 7.0703125
▁of 0.11810302734375
▁female 4.45703125
▁patients 0.71923828125
▁was 1.71875
▁remark 9.53125
ably 0.00047278404235839844
▁higher 0.4306640625
▁in 3.09375
▁the 1.669921875
▁op 4.5703125
i 4.43359375
ates 0.11871337890625
▁group 0.278076171875
▁compared 2.439453125
▁to 0.12310791015625
▁the 0.55322265625
▁MM 0.424560546875
▁group 0.276123046875
. 0.396484375
▁In 2.890625
▁turn 4.6328125
, 0.0022830963134765625
▁people 5.80078125
▁on 5.734375
▁op 1.375
i 0.40771484375
ates 0.0030879974365234375
▁were 1.1015625
▁more 1.044921875
▁likely 0.367431640625
▁to 0.053863525390625
▁report 2.76171875
▁major 6.12890625
▁de 0.51513671875
press 1.0693359375
ive 0.007965087890625
▁dis 0.70166015625
orders 1.1064453125
. 1.736328125
<0x0A> 2.6640625
Am 6.390625
ong 0.007312774658203125
▁all 2.412109375
▁participants 1.8701171875
▁in 3.1875
▁the 0.1331787109375
▁study 0.369384765625
, 0.057708740234375
▁ 0.61279296875
4 1.716796875
2 2.841796875
. 1.27734375
2 2.326171875
% 0.1611328125
▁suffered 4.33203125
▁from 0.093994140625
▁de 1.271484375
pression 0.2200927734375
, 1.1611328125
▁and 1.7998046875
▁ 0.19580078125
3 1.7236328125
7 2.193359375
% 2.685546875
▁experienced 2.380859375
▁excess 7.8125
ive 0.07196044921875
▁anx 0.28857421875
iety 0.0031337738037109375
. 0.368896484375
▁The 1.37109375
▁pl 11.2734375
ur 0.81591796875
ality 0.00018346309661865234
▁of 0.1834716796875
▁de 3.62890625
press 1.130859375
ive 0.0294952392578125
▁dis 1.849609375
orders 0.050384521484375
▁among 3.798828125
▁patients 1.1748046875
▁in 3.345703125
▁the 0.3759765625
▁op 1.6123046875
i 0.89013671875
ates 0.005077362060546875
, 7.56640625
▁medical 2.982421875
▁mar 0.0207672119140625
iju 0.00623321533203125
ana 7.152557373046875e-05
, 0.135986328125
▁and 0.05792236328125
▁mixed 6.3046875
▁OP 8.9609375
MM 6.546875
▁groups 0.4189453125
▁number 8.3359375
ed 0.008544921875
▁ 0.1353759765625
5 2.408203125
7 2.5546875
. 0.190185546875
1 2.37890625
%, 0.255859375
▁ 0.00445556640625
2 3.193359375
2 2.46484375
. 0.1075439453125
3 2.220703125
%, 0.115234375
▁and 0.0290374755859375
▁ 0.002674102783203125
5 3.208984375
1 2.4296875
. 0.1710205078125
4 2.1484375
%, 0.378173828125
▁respectively 0.00942230224609375
. 0.2401123046875
▁The 1.3974609375
▁pl 4.61328125
ur 0.0209503173828125
ality 3.159046173095703e-05
▁of 0.0423583984375
▁anx 0.8349609375
iety 0.00811004638671875
▁contained 11.203125
▁ 0.458740234375
4 1.6455078125
8 2.38671875
. 0.063720703125
4 2.310546875
% 0.5107421875
▁among 1.6279296875
▁OP 6.33203125
▁patients 8.9140625
, 0.3046875
▁ 0.127197265625
2 1.5615234375
1 2.427734375
. 0.14111328125
5 2.423828125
% 0.01131439208984375
▁among 0.388427734375
▁MM 0.463623046875
▁patients 0.2166748046875
, 0.01111602783203125
▁and 0.01319122314453125
▁ 0.03985595703125
3 1.26171875
8 2.623046875
. 0.16748046875
7 2.287109375
% 0.01363372802734375
▁among 0.2310791015625
▁OP 4.21484375
MM 0.2080078125
▁participants 3.61328125
. 0.221923828125
▁Pat 5.89453125
ients 0.02081298828125
▁who 2.400390625
▁took 2.96484375
▁strong 7.859375
▁op 1.279296875
i 1.3876953125
ates 0.003795623779296875
▁were 1.7197265625
▁t 9.109375
ended 1.3447265625
▁to 0.01168060302734375
▁place 10.125
▁their 3.701171875
▁pain 2.7109375
▁on 3.4765625
▁a 0.96728515625
▁scale 2.666015625
▁of 0.59619140625
▁ 0.349365234375
9 2.869140625
▁to 1.41796875
▁ 0.0157470703125
1 0.0289154052734375
0 0.061859130859375
▁( 2.62109375
Fe 1.86328125
ing 0.0059051513671875
old 0.0003154277801513672
▁et 0.0343017578125
▁al 0.0008568763732910156
., 0.006229400634765625
▁ 0.001598358154296875
2 0.0005750656127929688
0 0.00017976760864257812
1 0.0017070770263671875
7 0.01087188720703125
). 0.053375244140625
▁They 4.38671875
▁were 1.232421875
▁also 1.3818359375
▁an 8.875
gu 4.91015625
ished 0.031494140625
▁em 8.015625
otion 0.01006317138671875
ally 0.002597808837890625
▁and 1.095703125
▁react 7.0
ed 0.046783447265625
▁rad 9.71875
ically 0.002429962158203125
▁neg 5.3515625
atively 0.0007500648498535156
▁to 0.40185546875
▁almost 5.453125
▁all 1.1494140625
▁survey 7.8125
▁questions 0.59375
. 0.265625
▁Pat 4.21484375
ients 0.00902557373046875
▁who 1.3095703125
▁took 1.529296875
▁only 5.20703125
▁MM 0.8486328125
▁or 3.146484375
▁mixed 3.228515625
▁medic 2.990234375
ations 0.323486328125
▁course 12.4609375
▁had 2.455078125
▁a 1.2333984375
▁significantly 2.537109375
▁more 3.962890625
▁stable 3.45703125
▁emot 1.033203125
ional 0.00872802734375
▁state 0.9326171875
▁and 1.357421875
▁cop 5.57421875
ed 0.86181640625
▁with 0.728515625
▁pain 1.3779296875
▁more 1.6171875
▁manage 6.6015625
able 2.494140625
. 0.495849609375
<0x0A> 0.6240234375
One 5.1484375
▁of 0.53955078125
▁the 0.0184173583984375
▁major 2.5078125
▁limitations 2.92578125
▁is 4.16015625
▁the 0.5458984375
▁ins 4.828125
u 0.0237579345703125
fficient 0.11993408203125
ly 4.62890625
▁high 2.900390625
▁response 3.28515625
▁rate 0.1068115234375
, 2.916015625
▁ 4.37890625
5 1.96484375
7 2.06640625
% 2.150390625
▁instead 7.4375
▁of 0.00588226318359375
▁ 0.6884765625
7 1.6171875
0 1.4638671875
% 1.0693359375
▁( 1.6025390625
Fe 0.2088623046875
ing 0.0029697418212890625
old 0.00038170814514160156
▁et 0.006534576416015625
▁al 0.0005745887756347656
., 0.003932952880859375
▁ 0.0011072158813476562
2 0.0003693103790283203
0 4.839897155761719e-05
1 0.0008072853088378906
7 0.00482177734375
). 0.03466796875
▁It 2.7734375
▁can 3.3984375
▁be 0.380615234375
▁fairly 8.125
▁explained 1.6201171875
▁by 0.2010498046875
▁the 0.319091796875
▁weak 8.1015625
▁focus 7.06640625
▁of 0.447509765625
▁respond 6.67578125
ents 0.1590576171875
▁who 3.55859375
▁have 4.11328125
▁overcome 8.1015625
▁severe 2.283203125
▁pain 0.53955078125
▁sens 8.7109375
ations 1.1533203125
▁and 1.1982421875
▁de 3.91796875
press 1.6728515625
ive 0.219482421875
▁episodes 3.958984375
. 0.59765625
▁It 3.376953125
▁is 0.853515625
▁not 2.755859375
▁clear 3.96484375
▁how 1.6640625
▁to 3.66796875
▁use 5.3203125
▁these 3.076171875
▁statistics 3.439453125
, 2.650390625
▁as 2.01171875
▁they 1.626953125
▁still 5.61328125
▁may 5.0234375
▁be 1.2578125
▁relevant 5.671875
▁for 1.4091796875
▁the 1.849609375
▁overall 4.6640625
▁analysis 3.5625
. 1.146484375
